AGREEMENTAgreement • September 2nd, 2008 • GrowthWorks Capital Ltd. • In vitro & in vivo diagnostic substances
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Oncogenex Pharmaceuticals, Inc.
ESCROW AGREEMENTEscrow Agreement • September 2nd, 2008 • GrowthWorks Capital Ltd. • In vitro & in vivo diagnostic substances • British Columbia
SONUS PHARMACEUTICALS, INC., to be renamed OncoGenex Pharmaceuticals, Inc., a corporation existing under the laws of the State of Delaware
